Timothy Watson

434 total citations
19 papers, 302 citations indexed

About

Timothy Watson is a scholar working on Organic Chemistry, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, Timothy Watson has authored 19 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 4 papers in Economics and Econometrics and 3 papers in Molecular Biology. Recurrent topics in Timothy Watson's work include Asymmetric Synthesis and Catalysis (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Chemical Synthesis and Analysis (2 papers). Timothy Watson is often cited by papers focused on Asymmetric Synthesis and Catalysis (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Chemical Synthesis and Analysis (2 papers). Timothy Watson collaborates with scholars based in United States, United Kingdom and Australia. Timothy Watson's co-authors include Joel M. Hawkins, Michael Hird, Kenneth J. Toyne, Roger Nosal, John W. Goodby, David J. am Ende, Jason Mustakis, Arun K. Ghosh, Janice E. Sieser and Stéphane Caron and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Chemical Communications.

In The Last Decade

Timothy Watson

17 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Watson United States 8 146 82 58 50 47 19 302
Carlos A. Franca Argentina 12 110 0.8× 74 0.9× 73 1.3× 58 1.2× 25 0.5× 33 335
Kyle R. Leeman United States 11 234 1.6× 62 0.8× 108 1.9× 38 0.8× 24 0.5× 17 359
Shaikha S. AlNeyadi United Arab Emirates 10 200 1.4× 38 0.5× 62 1.1× 65 1.3× 16 0.3× 31 327
Aabid A. Wani India 12 217 1.5× 41 0.5× 88 1.5× 32 0.6× 19 0.4× 27 330
Nga M. United States 8 242 1.7× 75 0.9× 141 2.4× 37 0.7× 40 0.9× 15 385
Sheng Cui United States 12 315 2.2× 90 1.1× 80 1.4× 42 0.8× 66 1.4× 29 465
Ladislav Habala Slovakia 12 165 1.1× 57 0.7× 90 1.6× 43 0.9× 41 0.9× 29 394
Srinivas Tummala United States 10 193 1.3× 66 0.8× 69 1.2× 54 1.1× 84 1.8× 17 342
Bushra Parveen Pakistan 11 245 1.7× 44 0.5× 63 1.1× 38 0.8× 18 0.4× 34 350
Lucius T. Rossano United States 11 253 1.7× 55 0.7× 137 2.4× 36 0.7× 36 0.8× 13 382

Countries citing papers authored by Timothy Watson

Since Specialization
Citations

This map shows the geographic impact of Timothy Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Watson more than expected).

Fields of papers citing papers by Timothy Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Watson. The network helps show where Timothy Watson may publish in the future.

Co-authorship network of co-authors of Timothy Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Watson. A scholar is included among the top collaborators of Timothy Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Watson. Timothy Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Watson, Timothy, et al.. (2023). COVID-19 Private Pension Withdrawals and Unemployment Tenures. SSRN Electronic Journal.
2.
Watson, Timothy & Juha Tervala. (2023). Building the Education Revolution: The Employment Effects of Fiscal Stimulus in Australia. SSRN Electronic Journal. 2 indexed citations
3.
Cauchon, Nina S., Xiaohong Chen, Tao Li, et al.. (2022). Meeting report: Advancing accelerated regulatory review with Real-Time Oncology Review (RTOR), Project Orbis, and the Product Quality Assessment Aid. SHILAP Revista de lepidopterología. 8(1). 19–19. 2 indexed citations
4.
Breunig, Robert, et al.. (2022). COVID-19 Private Pension Withdrawals and Unemployment Tenures. SSRN Electronic Journal. 2 indexed citations
5.
Watson, Timothy, et al.. (2018). Misunderstanding Design Space: a Robust Drug Product Control Strategy Is the Key to Quality Assurance. Journal of Pharmaceutical Innovation. 13(3). 283–285. 6 indexed citations
6.
Bercu, Joel P., John C. Berridge, Barry Cherney, et al.. (2018). Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities. Journal of Pharmaceutical Innovation. 14(1). 76–89. 26 indexed citations
8.
Watson, Timothy, et al.. (2016). The Selection and Control of Starting Materials Should be Governed by Science and Risk-Based Approaches. The AAPS Journal. 19(1). 1–3. 7 indexed citations
9.
Watson, Timothy, Stephen T. Colgan, Michael P. Lynch, et al.. (2013). A Design Space Verification Protocol for a Small Molecule Drug Substance. Journal of Pharmaceutical Innovation. 8(2). 67–71. 1 indexed citations
10.
Colgan, Stephen T., et al.. (2012). The Application of Science- and Risk-Based Concepts to Drug Substance Stability Strategies. Journal of Pharmaceutical Innovation. 7(3-4). 205–213. 12 indexed citations
11.
Ende, David J. am, et al.. (2010). A Science and Risk Based Proposal for Understanding Scale and Equipment Dependencies of Small Molecule Drug Substance Manufacturing Processes. Journal of Pharmaceutical Innovation. 5(3). 72–78. 6 indexed citations
13.
Ende, David J. am, et al.. (2007). API Quality by Design Example from the Torcetrapib Manufacturing Process. Journal of Pharmaceutical Innovation. 2(3-4). 71–86. 36 indexed citations
14.
Andresen, Brian M., John L. Tucker, Janice E. Sieser, et al.. (2006). Process Research and Scale-up of the κ-Opioid Receptor Agonist CJ-15,161 Drug Candidate. CHIMIA International Journal for Chemistry. 60(9). 554–554. 4 indexed citations
15.
Hawkins, Joel M. & Timothy Watson. (2004). Asymmetric Catalysis in the Pharmaceutical Industry. Angewandte Chemie International Edition. 43(25). 3224–3228. 119 indexed citations
16.
Hawkins, Joel M. & Timothy Watson. (2004). Asymmetrische Katalyse in der pharmazeutischen Industrie. Angewandte Chemie. 116(25). 3286–3290. 23 indexed citations
17.
Ghosh, Arun K., Janice E. Sieser, Stéphane Caron, & Timothy Watson. (2002). Synthesis of the kappa-agonist CJ-15,161 via a palladium-catalyzed cross-coupling reaction. Chemical Communications. 1644–1645. 13 indexed citations
18.
Goodby, John W., Michael Hird, Kenneth J. Toyne, & Timothy Watson. (1994). A novel, efficient and general synthetic route to unsymmetrical triphenylene mesogens using palladium-catalysed cross-coupling reactions. Journal of the Chemical Society Chemical Communications. 1701–1701. 38 indexed citations
19.
Paquette, Leo A., Timothy Watson, & Dirk Friedrich. (1993). Multiple functionalization of medium-sized carbocyclic rings. From cyclooctanone to a 1,5-dialkoxycyclooctatetraene. The Journal of Organic Chemistry. 58(3). 776–778. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026